(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
Capstan Medical Achieves First Robotic-Assisted Mitral Valve Implants
Capstan Medical has successfully completed the first-ever robotic-assisted mitral valve replacement procedures, marking a significant advancement in structural heart disease treatment. The Santa Cruz-based startup aims to offer a minimally invasive alternative for patients ineligible for existing heart valve procedures.
The company is developing a robotic delivery platform, combining a compact valve, catheter, and robotic system to address challenges in mitral and tricuspid valve replacement. Unlike traditional devices, Capstan’s valve avoids blocking the cardiac outflow tract, a key reason many patients are excluded from treatment.
Current Landscape & Challenges:
- 80% of patients seeking mitral valve replacement are excluded due to anatomical constraints.
- Market leaders like Edwards Lifesciences and Abbott focus primarily on valve repair, with limited options for full replacement.
- Capstan’s catheter design offers greater precision and control, enhancing procedural success.
This breakthrough could expand treatment access for patients with complex mitral and tricuspid disease, where minimally invasive solutions have lagged behind aortic valve advancements.
13-03-2025